OXFORD COVID-19 VACCINE : AZD1222

OXFORD COVID-19 VACCINE : AZD1222


The vaccine did not prompt any serious side effects and elicited antibody and T-cell immune responses, according to trial results published in The Lancet medical journal.


London: 

An experimental COVID-19 vaccine, being developed by the University of Oxford, was safe and produced an immune response in early-stage clinical trials in healthy volunteers, data showed on Monday.

The vaccine, called AZD1222 and being developed by pharmaceutical company AstraZeneca and scientists at Britain's University of Oxford, did not prompt any serious side effects and elicited antibody and T-cell immune responses, according to trial results published in The Lancet medical journal.

Comments

Popular posts from this blog

Ansys Products 2020R1 x64 SSQ/ Free Download / crack/

Statue of Unity: Symbol of Pride or Wastage of Public Money?

FAU-G an Indian Alternative to PUBG !!!!